April 2012

TABLE OF CONTENTS

EXECUTIVE INTERVIEW – 3M DDS: Helping Customers Compete & Innovate

James D. Ingebrand, VP & General manager of 3M DDS, discusses his priorities for the years ahead and recent developments in 3M’s technologies.

DRUG DEVELOPMENT – Design & Development of Atorvastatin Orally Disintegrating Tablets & Their Evaluation by Electronic Tongue

Rakesh Kumar Bhasin, MPharm, and Pradip Kumar Ghosh, PhD, design and develop a good taste-masked atorvastatin ODT that matched the in vitro release profile of Lipitor.

MANAGEMENT INSIGHT – Follow the Capital

Derek G. Hennecke continues with part 2 of his 6-part series on lessons learned from other industries.

FORMULATION DEVELOPMENT – Particle Sizing Across the Drug Development Cycle

Carl Levoguer, PhD, examines how laser diffraction technology has been fashioned to powerfully support every stage of the drug development cycle.

EXCIPIENTS – Polymers for Solid Oral Dosage Forms

Robert Gwozdz, MPharm, presents an overview of polymers used in the more exotic and technically challenging dosage forms involving MR as well as those used for enhancing the dissolution and bioavailability of poorly soluble APIs.

EXECUTIVE INTERVIEW – Ratio, Inc.: Making Self-Injection Simple, Safe & Affordable

Mr. Ben Moga, President of Ratio, Inc., talks about his company’s focus on self-injection in a homecare setting and how Ratio is pitting the patch injector against conventional autoinjectors in what is projected to be a $15.8 billion injectable drug delivery device market.

MANUFACTURING – The Case for Automating the Contract Lifecycle

James Burke believes companies adopting ECLM solutions to automate the contract lifecycle would be well advised to understand the business problem they are trying to solve and do the diligence to see where automation makes sense and where it doesn’t for their contracting process.

MARKET BRIEF – US Market for IV Packaging to Reach $295 Million in 2014

Bill Martineau, MBA, believes LVPs represent one of the highest value-added applications for pharmaceutical packaging. Nonetheless, demand for IV containers will expand at a lackluster pace due to trends promoting short hospital stays and less-invasive surgeries.

COVER

FEATURES